Dipentum

Product NDC
68151-0312
11-digit product format
681510312
Labeler code
68151
Product ID
68151-0312_75c040b8-d3c3-4df8-adb9-af948f9bc0dd
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
olsalazine sodium
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Labeler
Carilion Materials Management
Application
NDA019715
Marketing category
NDA
Marketing start
2015-05-15
Marketing end
0000-00-00
Substance
OLSALAZINE SODIUM
Active strength
250 mg/1
Pharmacologic classes
Aminosalicylate [EPC],Aminosalicylic Acids [CS]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6caced09-10d9-0a78-cc7d-35b444e1642bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68151-0312-1Dipentum1 in 1 BLISTER PACKCAPSULE, GELATIN COATED13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68151-0312DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]3Legacy NDC, 1 package rows20171227_9dd522a3-587e-44ab-9de3-a0fd079f2ffb.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
905164Dipentum 250 MG Oral CapsulePSN9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905162olsalazine sodium 250 MG Oral CapsulePSN9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905164olsalazine sodium 250 MG Oral Capsule [Dipentum]SBD9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905162olsalazine sodium 250 MG Oral CapsuleSCD9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905164Dipentum 250 MG Oral CapsuleSY9dd522a3-587e-44ab-9de3-a0fd079f2ffb3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
68151-0312-1681510312011 in 1 BLISTER PACKHistorical